Skip to main content
Log in

Cancer survivorship practices, services, and delivery: a report from the Children’s Oncology Group (COG) nursing discipline, adolescent/young adult, and late effects committees

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

To describe survivorship services provided by the Children’s Oncology Group (COG), an assessment of services was undertaken. Our overall aims were (1) to describe survivorship services, including the extent of services provided, resources (personnel, philanthropy, and research funding), billing practices, and barriers to care and 2) to describe models of care that are in use for childhood cancer survivors and adult survivors of childhood cancer.

Methods

One hundred seventy-nine of 220 COG institutions (81%) completed an Internet survey in 2007.

Results

One hundred fifty-five (87%) reported providing survivorship care. Fifty-nine percent of institutions provide care for their pediatric population in specialized late effects programs. For adult survivors, 47% of institutions chose models of care, which included transitioning to adult providers for risk-based health care, while 44% of institutions keep survivors indefinitely at the treating institution (Cancer Center Based Model without Community Referral). Sixty-eight percent provide survivors with a copy of their survivorship care plan. Only 31% of institutions provide a detailed summary of results after each clinic visit, and 41% have a database to track survivor health outcomes. Minimal time required for initial and annual survivorship visits is estimated to be approximately 120 and 90 min, respectively. The most prevalent barriers to care were the lack of dedicated time for program development and a perceived insufficient knowledge on the part of the clinician receiving the transition referral.

Conclusions

Not all COG institutions provide dedicated survivorship care, care plans, or have databases for tracking outcomes. Transitioning to adult providers is occurring within the COG. Survivorship care is time intensive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

    Article  PubMed  Google Scholar 

  2. Hewitt M, Weiner S, Simone J. Childhood cancer survivorship: improving care and quality of life. Washington: National Academies Press; 2003.

    Google Scholar 

  3. Mariotto AB, Rowland JH, Yabroff KR, Scoppa S, Hachey M, Ries L, et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18:1033–40.

    Article  PubMed  Google Scholar 

  4. Oeffinger KC, Eshelman DA, Tomlinson GE, Buchanan GR, Foster BM. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer. 2000;88:1687–95.

    Article  PubMed  CAS  Google Scholar 

  5. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.

    Article  PubMed  CAS  Google Scholar 

  6. Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2328–38.

    Article  PubMed  CAS  Google Scholar 

  7. Armstrong GT, Sklar CA, Hudson MM, Robison LL. Long-term health status among survivors of childhood cancer: does sex matter? J Clin Oncol. 2007;25:4477–89.

    Article  PubMed  Google Scholar 

  8. Askins MA, Moore 3rd BD. Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol. 2008;23:1160–71.

    Article  PubMed  Google Scholar 

  9. Bonato C, Severino RF, Elnecave RH. Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radiotherapy. J Pediatr Endocrinol Metab. 2008;21:943–9.

    Article  PubMed  Google Scholar 

  10. Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:5277–82.

    Article  PubMed  Google Scholar 

  11. De Bruin ML, Van Dulmen-den Broeder E, Van den Berg MH, Lambalk CB. Fertility in female childhood cancer survivors. Endocr Dev. 2009;15:135–58.

    Article  PubMed  Google Scholar 

  12. Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290:1583–92.

    Article  PubMed  CAS  Google Scholar 

  13. Janiszewski PM, Oeffinger KC, Church TS, Dunn AL, Eshelman DA, Victor RG, et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2007;92:3816–21.

    Article  PubMed  CAS  Google Scholar 

  14. Kaste SC. Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer. 2008;50:469–73. discussion 86.

    Article  PubMed  Google Scholar 

  15. Maule M, Scelo G, Pastore G, Brennan P, Hemminki K, Pukkala E, et al. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study. Eur J Cancer. 2008;44:830–9.

    Article  PubMed  CAS  Google Scholar 

  16. Mitby PA, Robison LL, Whitton JA, Zevon MA, Gibbs IC, Tersak JM, et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2003;97:1115–26.

    Article  PubMed  Google Scholar 

  17. Nagarajan R, Mogil R, Neglia JP, Robison LL, Ness KK. Self-reported global function among adult survivors of childhood lower-extremity bone tumors: a report from the Childhood Cancer Survivor Study (CCSS). J Cancer Surviv. 2009;3:59–65.

    Article  PubMed  Google Scholar 

  18. Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L. Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group. Horm Res. 2008;69:65–74.

    Article  PubMed  CAS  Google Scholar 

  19. Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98:1528–37.

    Article  PubMed  Google Scholar 

  20. Reilly JJ. Obesity during and after treatment for childhood cancer. Endocr Dev. 2009;15:40–58.

    Article  PubMed  Google Scholar 

  21. Ritchey M, Ferrer F, Shearer P, Spunt SL. Late effects on the urinary bladder in patients treated for cancer in childhood: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009;52:439–46.

    Article  PubMed  Google Scholar 

  22. Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, et al. Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005;104:2557–64.

    Article  PubMed  Google Scholar 

  23. Shnorhavorian M, Friedman DL, Koyle MA. Genitourinary long-term outcomes for childhood cancer survivors. Curr Urol Rep. 2009;10:134–7.

    Article  PubMed  Google Scholar 

  24. Crom DB, Lensing SY, Rai SN, Snider MA, Cash DK, Hudson MM. Marriage, employment, and health insurance in adult survivors of childhood cancer. J Cancer Surviv. 2007;1:237–45.

    Article  PubMed  Google Scholar 

  25. Gurney JG, Krull KR, Kadan-Lottick N, Nicholson HS, Nathan PC, Zebrack B, et al. Social outcomes in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27:2390–5.

    Article  PubMed  Google Scholar 

  26. Chen MH, Colan SD, Diller L. Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res. 2011;108:619–28.

    Article  PubMed  CAS  Google Scholar 

  27. Mostoufi-Moab S, Grimberg A. Pediatric brain tumor treatment: growth consequences and their management. Pediatr Endocrinol Rev. 2010;8:6–17.

    PubMed  Google Scholar 

  28. Robinson KE, Kuttesch JF, Champion JE, Andreotti CF, Hipp DW, Bettis A, et al. A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors. Pediatr Blood Cancer. 2010;55:525–31.

    Article  PubMed  Google Scholar 

  29. Fulbright JM. Review of cardiotoxicity in pediatric cancer patients: during and after therapy. Cardiol Res Pract. 2011;2011:942090.

    PubMed  Google Scholar 

  30. Castellino S, Muir A, Shah A, Shope S, McMullen K, Ruble K, et al. Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2010;54:663–9.

    PubMed  Google Scholar 

  31. Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of childhood cancer: a systematic review. Chest 2011 (in press).

  32. Baker KS, Bresters D, Sande JE. The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children. Pediatr Clin North Am. 2010;57:323–42.

    Article  PubMed  Google Scholar 

  33. American Academy of Pediatrics Section on Hematology/Oncology. Long-term follow-up care for pediatric cancer survivors. Pediatrics. 2009;123:906–15.

    Article  Google Scholar 

  34. Freyer DR. Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches. J Clin Oncol. 2010;28:4810–8.

    Article  PubMed  Google Scholar 

  35. Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979–90.

    Article  PubMed  Google Scholar 

  36. Masera G, Chesler M, Jankovic M, Eden T, Nesbit ME, Van Dongen-Melman J, et al. SIOP working committee on psychosocial issues in pediatric oncology: Guidelines for care of long-term survivors. Medical and Pediatric Oncology. 1996;27:1–2.

    Article  PubMed  CAS  Google Scholar 

  37. Scottish Intercollegiate Guidelines Network (SIGN). Long-term follow-up of survivors of childhood cancer: a national clinical guideline. http://www.sign.ac.uk/pdf/sign76.pdf (2004).

  38. Skinner R, Wallace WHB, Levitt GA. Therapy based long term follow up: practice Statement. Leicester: United Kingdom Children’s Cancer Study Group (Late Effects Group); 2005.

    Google Scholar 

  39. Boeije H. A Purposeful approach to the constant comparative method in the analysis of qualitative interviews. Quality Quantity. 2002;36:391–409.

    Article  Google Scholar 

  40. Friedman DL, Freyer DR, Levitt GA. Models of care for survivors of childhood cancer. Pediatr Blood Cancer. 2006;46:159–68.

    Article  PubMed  Google Scholar 

  41. American Medical Association. CPT 2010 Professional Edition; 2010.

  42. Taylor A, Hawkins M, Griffiths A, Davies H, Douglas C, Jenney M, et al. Long-term follow-up of survivors of childhood cancer in the UK. Pediatr Blood Cancer. 2004;42:161–8.

    Article  PubMed  Google Scholar 

  43. Oeffinger KC, Eshelman DA, Tomlinson GE, Buchanan GR. Programs for adult survivors of childhood cancer. J Clin Oncol. 1998;16:2864–7.

    PubMed  CAS  Google Scholar 

  44. Guilcher GM, Fitzgerald C, Pritchard S. A questionnaire based review of long-term follow-up programs for survivors of childhood cancer in Canada. Pediatr Blood Cancer. 2009;52:113–5.

    Article  PubMed  CAS  Google Scholar 

  45. Aziz NM, Oeffinger KC, Brooks S, Turoff AJ. Comprehensive long-term follow-up programs for pediatric cancer survivors. Cancer. 2006;107:841–8.

    Article  PubMed  Google Scholar 

  46. Hudson MM, Hester A, Sweeney T, Kippenbrock S, Majcina R, Vear S, et al. A model of care for childhood cancer survivors that facilitates research. J Pediatr Oncol Nurs. 2004;21:170–4.

    Article  PubMed  Google Scholar 

  47. Kenney LB, Bradeen H, Kadan-Lottick NS, Diller L, Homans A, Schwartz CL. The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the consortium for New England childhood cancer survivors. Pediatr Blood Cancer 2011 (in press).

  48. Bowers DC, Adhikari S, El-Khashab YM, Gargan L, Oeffinger KC. Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors. Pediatr Blood Cancer. 2009;53:1295–301.

    Article  PubMed  Google Scholar 

  49. Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26:4401–9.

    Article  PubMed  Google Scholar 

  50. Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol. 2006;24:5117–24.

    Article  PubMed  Google Scholar 

  51. Oeffinger KC, Nathan PC, Kremer LC. Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Pediatr Clin North Am. 2008;55:251–73. xiii.

    Article  PubMed  Google Scholar 

  52. Mertens AC, Cotter KL, Foster BM, Zebrack BJ, Hudson MM, Eshelman D, et al. Improving health care for adult survivors of childhood cancer: recommendations from a delphi panel of health policy experts. Health Policy. 2004;69:169–78.

    Article  PubMed  Google Scholar 

  53. Zebrack BJ, Eshelman DA, Hudson MM, Mertens AC, Cotter KL, Foster BM, et al. Health care for childhood cancer survivors: insights and perspectives from a Delphi panel of young adult survivors of childhood cancer. Cancer. 2004;100:843–50.

    Article  PubMed  Google Scholar 

  54. Skinner R, Wallace WH, Levitt GA. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol. 2006;7:489–98.

    Article  PubMed  Google Scholar 

  55. Freyer DR, Brugieres L. Adolescent and young adult oncology: transition of care. Pediatr Blood Cancer. 2008;50:1116–9.

    Article  PubMed  Google Scholar 

  56. Skinner R, Wallace WH, Levitt G. Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how? Arch Dis Child. 2007;92:257–60.

    Article  PubMed  Google Scholar 

  57. Eshelman-Kent D, Gilger E, Gallagher M. Transitioning survivors of central nervous system tumors: challenges for patients, families, and health care providers. J Pediatr Oncol Nurs. 2009;26:280–94.

    Article  PubMed  Google Scholar 

  58. Nathan PC, Hayes-Lattin B, Sisler JJ, Hudson MM. Critical issues in transition and survivorship for adolescents and young adults with cancers. Cancer. 2011;117:2335–41.

    Article  PubMed  Google Scholar 

  59. Casillas J, Kahn KL, Doose M, Landier W, Bhatia S, Hernandez J, et al. Transitioning childhood cancer survivors to adult-centered healthcare: insights from parents, adolescent, and young adult survivors. Psychooncology. 2010;19:982–90.

    Article  PubMed  Google Scholar 

  60. Bober SL, Recklitis CJ, Campbell EG, Park ER, Kutner JS, Najita JS, et al. Caring for cancer survivors: a survey of primary care physicians. Cancer. 2009;115:4409–18.

    Article  PubMed  Google Scholar 

  61. Okumura MJ, Kerr EA, Cabana MD, Davis MM, Demonner S, Heisler M. Physician views on barriers to primary care for young adults with childhood-onset chronic disease. Pediatrics. 2010;125:e748–54.

    Article  PubMed  Google Scholar 

  62. Betz CL. Health care transitions of youth with special health care needs: the never ending journey. Commun Nurs Res. 2008;41:13–29.

    PubMed  Google Scholar 

  63. Binks JA, Barden WS, Burke TA, Young NL. What do we really know about the transition to adult-centered health care? A focus on cerebral palsy and spina bifida. Arch Phys Med Rehabil. 2007;88:1064–73.

    Article  PubMed  Google Scholar 

  64. Marelli AJ, Therrien J, Mackie AS, Ionescu-Ittu R, Pilote L. Planning the specialized care of adult congenital heart disease patients: from numbers to guidelines; an epidemiologic approach. Am Heart J. 2009;157:1–8.

    Article  PubMed  Google Scholar 

  65. Shirodaria CC, Gwilt DJ, Gatzoulis MA. Joint outpatient clinics for the adult with congenital heart disease at the district general hospital: an alternative model of care. Int J Cardiol. 2005;103:47–50.

    Article  PubMed  CAS  Google Scholar 

  66. Telfair J, Alleman-Velez PL, Dickens P, Loosier PS. Quality health care for adolescents with special health-care needs: issues and clinical implications. J Pediatr Nurs. 2005;20:15–24.

    Article  PubMed  Google Scholar 

  67. Hagood JS, Lenker CV, Thrasher S. A course on the transition to adult care of patients with childhood-onset chronic illnesses. Acad Med. 2005;80:352–5.

    Article  PubMed  Google Scholar 

  68. LoCasale-Crouch J, Johnson B. Transition from pediatric to adult medical care. Adv Chronic Kidney Dis. 2005;12:412–7.

    Article  PubMed  Google Scholar 

  69. McDonagh JE. Growing up and moving on: transition from pediatric to adult care. Pediatr Transplant. 2005;9:364–72.

    Article  PubMed  Google Scholar 

  70. McDonagh JE, Viner RM. Lost in transition? Between paediatric and adult services. BMJ. 2006;332:435–6.

    Article  PubMed  Google Scholar 

  71. Oeffinger KC, Mertens AC, Hudson MM, Gurney JG, Casillas J, Chen H, et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med. 2004;2:61–70.

    Article  PubMed  Google Scholar 

  72. Ginsberg JP, Hobbie WL, Carlson CA, Meadows AT. Delivering long-term follow-up care to pediatric cancer survivors: transitional care issues. Pediatr Blood Cancer. 2006;46:169–73.

    Article  PubMed  Google Scholar 

  73. Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, et al. Childhood cancer survivors' knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. JAMA. 2002;287:1832–9.

    Article  PubMed  Google Scholar 

  74. Poplack D, Fordis M, Horowitz ME, Landier W, Hudson MM, Bhatia S, et al. The passport for care improving the lives of childhood cancer survivors: development of a novel internet resource for managing long-term health risks. In: Hewitt M, Ganz P, National Coalition for Cancer Survivorship (US) et al., editors. Implementing cancer survivorship care planning. Washington: The National Academies Press; 2007. pp. 206–41.

  75. Fergusson J, Ruccione K, Waskerwitz M, Perin G, Diserens D, Nesbit M, et al. Time required to assess children for the late effects of treatment. A report from the Childrens Cancer Study Group. Cancer Nurs. 1987;10:300–10.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported in part by the Children's Oncology Group Chair's Grant U10 CA098543 from the National Cancer Institute.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Debra Eshelman-Kent.

Additional information

Preliminary data from this study was presented in poster at the 10th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Niagara on the Lake, Canada, June 2008.

Appendices

Appendix A. State of Late Effects (LE) Services in COG

  1. 1

    Only one set of answers is needed for each institution in COG.

Before proceeding please check with others at your institution to determine if your institutional information has already been submitted.

The survey will take approximately 15–20 minutes to complete. You can come back to re-enter data at any time; however, the program will not "remember" where you left off, so you will need to start from the beginning. Therefore, it is advisable to complete the entire survey at one time.

  1. 2

    Please choose your institution from the drop down menu provided.

If you are having difficulty finding your institution, please contactDebra Eshelman-Kent via e-mail at debra.kent@cchmc.org or Karen Kinahan at K-Kinahan@northwestern.edu.

  1. 3

    Please provide the following information.

Name (last, first)

Credentials

E-mail Address

  1. 4

    Does your institution provide late effects care for childhood cancer survivors?

  2. 5

    How does your institution provide late effects care? (choose only one)

In a specialized LE program by designated provider(s)

In regular oncology clinic by health care professional staffing clinic that day

In regular oncology clinic by survivor's treating oncologist

Other, please specify

  1. 6

    What are the eligibility criteria for entry into LE services at your institution? (check all that apply)

at least 2 years off treatment

at least 3 years off treatment

at least 5 years off treatment

at least 5 years from diagnosis

Other, please describe

  1. 7

    Are BMT /stem cell transplant survivors eligible for LE services?

  2. 8

    What are the BMT/stem cell transplant survivors’ eligibility criteria for entry into LE services at your institution? (check all that apply)

at least 2 years off treatment

at least 3 years off treatment

at least 5 years off treatment

5 years from trnsplant

No active GVHD

Other, please explain

  1. 9

    Are children with central nervous system tumors eligible for LE services?

  2. 10

    What are the CNS survivor eligibility criteria for entry into LE services at your institution? (check any that apply)

at least 2 years off treatment

at least 3 years off treatment

at least 5 years off treatment

5 years from diagnosis

Other, please explain

  1. 11

    Are patients treated for disease other than oncologic illnesses (ex: aplastic anemia, histiocytosis) eligible for LE services?

  2. 12

    Does your program provide clinical consultations to survivors not treated at your institution?

  3. 13

    Does your program provide phone consultations to survivors not treated at your institution?

  4. 14

    Can patients self refer for late effects services at your institution?

  5. 15

    Please supply demographic information that will be made accessible to survivors and health care professionals in the Late Effects Directory of Services.

Appendix B. General Information

  1. 16

    Please choose the average number of new oncology patients treated at your institution annually.

Less than 30 new oncology patients/year

  • 31–60 new oncology patients/year

  • 61–90 new oncology patients/year

  • 91–120 new oncology patients/year

  • 121–150 new oncology patients/year

Greater than 150 new oncology patiens/year

  1. 17

    In 2006, how many total survivors were eligible for late effects clinic visit/appointment?

  2. 18

    Of the following choices, please pick the one which best depicts the

ACTUAL number of survivor VISITS in 2006.

  • Less than 50 visits

  • 50–100 visits

  • 101–300 visits

  • 301–500 visits

  • 501–800 visits

  • Greater than 801 visits

  • Data not available

  1. 19

    How frequently are childhood cancer survivor appointments scheduled in your clinic? (please choose one)

  • one day/week

  • 2–3 days/week

  • 4–5 days/week

  • one day per month

  • two days per month

Other, please specify

  1. 20

    Per month, about how many survivors are typically seen (on average) in your late effects clinic setting/session.

# of Survivors per Month

  1. 21

    Please select which of the following routines describes how pediatric cancer survivors are followed in your institution for additional risk based care.

Survivors come to the late effects (LE) clinic and are referred to sub-specialsts at alternate times apart from their LE visit

Survivors come to clinic staffed by LE team and required sub-specialists

Survivors are seen by their general oncologist who manages their late effects care and are referred to sub-specialists at alternate times

Other, please describe

  1. 22

    If risk based screening is required (ex: echo) is it usually done at the same visit or on another day/time?

Same visit Another day/time

  1. 23

    Do all/almost all survivors receive a copy of their personal medical history, sometimes called an oncology medical summary or cancer treatment summary?

  2. 24

    If “yes”, who usually prepares/abstracts the data provided in it?

  3. 25

    Do survivors receive a detailed written account of their visit, with pertinent findings, after each visit?

  4. 26

    Please describe the average amount of time spent (in minutes per patient) on preparation of treatment summary.

  5. 27

    Please describe the average amount of time spent (in minutes per patient) on scheduling of appropriate tests/chart review prior to visit.

  6. 28

    Please describe the average amount of time spent (in minutes per patient) on initial LE visit (one-on-one patient time).

  7. 29

    Please describe the average amount of time spent (in minutes per patient) on annual LE visit (one-on-one patient time).

  8. 30

    Please describe the average amount of time spent (in minutes per patient) on gathering, interpreting and compiling lab results, special tests results, etc.

  9. 31

    Please describe the average amount of time spent (in minutes per patient) on post clinic conferencing.

  10. 32

    Please describe the average amount of time spent (in minutes per patient) on communication of findings to patient.

  11. 33

    What visit level are most routine/annual LE visits billed at? (If supplying information from oustide the US, please use "Other" to free-text how billing is done.)

  • Level 1 (CPT 99211)

  • Level 2 (CPT 99212)

  • Level 3 (CPT 99213)

  • Level 4 (CPT 99214)

  • Level 5 (CPT 99215)

Unknown

Other, please specify

  1. 34

    On a routine LE visit, which of the following professionals seeing a survivor would submit a bill for their services? (check all that apply)

  • MD

  • NP

  • PA

  • RN

  • Nutritionist

  • Social Worker

  • Education Specialist

  • Neuropsychologist

  • Psychologist

Other, please specify

Appendix C. Resources

  1. 35

    Does your institution provide financial support for your program operations? (Ex: Nurse coordinator salary funded by the institution or affiliated medical school)

  2. 36

    In the past 5 years has your institution had any level of philanthropic funding for salary support for some or all Late Effects personnel? (Not including government funding)

  3. 37

    In the past 5 years has your institution had philanthropic support (not as a part of research funding) which enables clinical care for patients?

(Ex: Parents against leukemia organization pays for an echo on noninsured patients)

  1. 38

    Does your institution currently have research funding specifically designated for clinical testing of patients in the context of a research study that the patient is enrolled in? (Ex: a free PFT for patients enrolled in a research study about lungs)

  2. 39

    How many nurse practitioners (NP)/clinical nurse specialists (CNS) does your program have?

  3. 40

    Approximately what percentage of the NP/CNS' job is spent on late effects?

  4. 41

    How many designated physician assistants (PA) does your program have?

  5. 42

    Approximately what percentage of the PA's job is spent on late effects?

  6. 43

    How many RN clinical coordinators (i.e. a person different than an NP) does your program have?

  7. 44

    Approximately what percentage of the RN clinical coordinator's job is spent on late effects?

  8. 45

    How many designated social workers does your program have?

  9. 46

    Approximately what percentage of the social worker's job is spent on late effects?

  10. 47

    How many designated administrative support staff /secretaries does your program have?

  11. 48

    Approximately what percentage of the administrative staff/secretary's job is spent on late effects?

  12. 49

    How many designated nutritionists does your program have?

  13. 50

    Approximately what percentage of the nutritionist's job is spent on late effects?

  14. 51

    How many designated educational specialists or neuropsychologists does your program have to help with survivor issues?

  15. 52

    Approximately what percentage of the educational specialist or neuropsychologist's job is spent on late effects?

  16. 53

    How many designated clinical research associates (CRA) does your program have?

  17. 54

    Approximately what percentage of the CRA's job is spent on late effects?

  18. 55

    Does your program provide dedicated personnel to solve insurance and/or employment related issues?

  19. 56

    Does your program have a database which is used to track survivor health care outcomes, and/or other pertinent clinical information about survivors?

If yes, type/name of database used (ex: Access, Oracle, etc.)

  1. 57

    Is there a fee for phone consultations discussing recommendation for risk based management for survivors?

  2. 58

    Is there a fee for preparation of cancer treatment summaries for any survivor?

Appendix D. Late Effects Services for Care of Survivors Once They Become Adults

  1. 59

    At what age (if applicable) are cancer survivors referred outside the treating/pediatric center for their cancer-related follow-up care?

We see our former pediatric cancer patients indefinitely at the treating institution and do not transition them elsewhere for their risk based care.

No age limitations, we transition survivors when survivor is ready.

Our survivors are seen through age 16, then transition elsewhere.

Our survivors are seen through age 18, then transition elsewhere.

Our survivors are seen through age 21, then transition elsewhere.

Other criteria: Please Describe.

  1. 60

    If your survivors are referred elsewhere in adulthood for their cancer related care (risk based late effects care) please pick the choice below that most accurately depicts how their cancer related/risk-based care is managed (select only one)

    1. a)

      In a specialized program for adult survivors of childhood cancer utilizing a primary care provider, with linkage and flow of information to the treating institution

    2. b)

      In a specialized program for adult survivors of childhood cancer utilizing a primary care adult practitioner and adult oncologist

By an adult oncologist in an adult cancer setting

  1. c)

    We refer back to the survivor’s general health care provider (family practice, internal medicine , gynecologist) in the community without specific flow of information back to us

  2. d)

    Other, explain

The survey is almost complete. Just a few more questions.

  1. 61

    Several models of cancer survivor care have been described in the literature. Please pick the one the most accurately depicts your LEservices for adult survivors of childhood cancer. Please read all choices carefully before selecting your answer:

    1. a)

      Cancer center based model WITH community referral: Survivors are transitioned at adulthood to their primary health care professional for routine cancer- related (LE) care. All late effects routine testing is managed and coordinated by their PCP with the LE (oncology) team primarily serving as consultants to multiple PCPs. In this model the LE team/treating oncologist have little to no direct patient care, and may be only peripherally involved.

    2. b)

      Cancer center based model WITHOUT community referral: Survivors are kept indefinitely at the treating institution for their cancer -related (LE) follow-up care. Generally care is with the same LE/oncology providers who provide care to the pediatric survivor population.

    3. c)

      Hybrid model (Combined cancer center and community based model): Survivors are transitioned to adult health care providers generally within the same health care system, with established opportunities (ie. a formal mechanism) for collaborative research, collaboration in clinical care, and/or other resource sharing. The LE (oncology) team and adult health care provider closely collaborate for survivor care.

    4. d)

      Postal/internet/phone based model: Survivors are dismissed from LE (oncology) follow-up at the cancer center. Contact is made regularly about survivor outcomes via postal, phone or internet based inquiry.

    5. e)

      None of the above (please describe below).

  1. 62

    If none of the above models describe your model, please describe your model for LE services for adult survivors of childhood cancer in detail (limit 500 characters).

  2. 63

    For your adolescent and young adult survivors, is specific information routinely provided by your late effects staff on the importance of health insurance and how to obtain/keep it?

  3. 64

    For your adolescent and young adult survivors, is specific information and support routinely provided by your late effects staff on career planning, vocational pathways or other issues related to obtaining a job?

  4. 65

    Please supply demographic information (as applicable) about your services for adult survivors of childhood cancer. This information will be made available on the COG Website to survivors and health care professionals pursuing adult late effects services.

Appendix E. Barriers

  1. 66

    Please choose the 2 most problematic barriers in caring for your pediatric cancer survivors

    1. a)

      Lack of dedicated time for late effects program development Survivor lack of health care insurance or insurance limitations

    2. b)

      Survivor knowledge deficit about the importance of maintaining cancer-related follow-up

    3. c)

      Lack of survivor desire to be followed by the LE team

    4. d)

      Not enough funding for support of program

    5. e)

      Lack of perceived need or support for LE services/program by other oncologists

    6. f)

      There are no barriers in my institution

    7. g)

      Other, describe

  1. 67

    From your perspective what are the two most difficult barriers you face (if any) in transitioning your survivors to adult care providers for cancer related care? (Please choose 2)

    1. a)

      Lack of knowledge about late effects by the clinician being referred to

    2. b)

      Survivor lack of health care insurance or insurance limitations

    3. c)

      Survivor knowledge deficit about the importance of maintaining cancer related follow-up into adulthood

    4. d)

      Lack of survivor desire to leave the comfort of the treating institution or oncologist

    5. e)

      Lack of survivor access to a primary care provider for reasons other than insurance such as geography

    6. f)

      Lack of oncology provider desire to “let go” of survivor

    7. g)

      Conflict between COG recommendations for risk based follow-up and adult health care provider recommendations

    8. h)

      We do not have any barriers

    9. i)

      Other, please specify

  1. 68

    Please describe any unique features about your LE follow-up that you feel have not been previously addressed (limit to 500 characters)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eshelman-Kent, D., Kinahan, K.E., Hobbie, W. et al. Cancer survivorship practices, services, and delivery: a report from the Children’s Oncology Group (COG) nursing discipline, adolescent/young adult, and late effects committees. J Cancer Surviv 5, 345–357 (2011). https://doi.org/10.1007/s11764-011-0192-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-011-0192-8

Keywords

Navigation